New Peer-Reviewed Publication on Laboratory Study That Demonstrated Simparica Trio® Protected 3x More Dogs From Infection With a Resistant Heartworm Isolate Than NexGard® Plus1

Drug-resistant heartworm is a growing concern for veterinarians and pet owners as resistant heartworm populations emerge. New research shows that not all heartworm preventives perform equally against ...
Morningstar%2c Inc.

Zoetis Receives Emergency Use Authorization for Simparica Trio® (sarolaner, moxidectin, and pyrantel chewable tablets) for Treatment of New World Screwworm Infestations in ...

Expands the solutions available to veterinarians to help address New World screwworm and gives added confidence for pet owners whose dogs and puppies are already receiving Simparica Trio Milestone ...

FDA authorizes emergency drug to help treat new world screwworm in dogs

The USDA had confirmed a total of 46 animal cases in Texas and New Mexico, with experts preparing for the threat to spread.
Medical Daily

FDA Authorizes Another Screwworm Treatment for Dogs as Officials Say Containment Is Still Holding

Novo Nordisk and Eli Lilly say GLP-1 drugs slowed aging clocks, but the data are early and unreviewed. Here is what patients should know. A study of 1.4 million women links pregnancy complications to ...
The Baltimore Sun

FDA approves an emergency drug for New World screwworm infestation in dogs

The Food and Drug Administration has approved a medication targeting New World screwworm infestations in adult dogs and puppies. The Emergency Use Authorization was issued for Simparica TRIO ...
AOL

Zoetis Receives Emergency Use Authorization for Simparica Trio® (sarolaner, moxidectin, and pyrantel chewable tablets) for Treatment of New World Screwworm Infestations in ...

Zoetis Inc. today announced that Simparica Trio has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for the treatment of infestations caused by New World ...